drugset / Trial / NCT06708637
Ocular Safety and Usability Study for FYB203 PFS
NaSingle-groupOpen-labelTreatment
Summary
The objective of the study is to assess the ocular safety of the FYB203 pre-filled syringe in terms of preparation and administration by Retina Specialists in the clinical setting.
Timeline
- Start
- 2024-09-20
- Primary completion
- 2024-10-08
- Completion
- 2024-10-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aflibercept | Protein / enzyme biologic | 2 mg | Intravitreal |